Covid-19 roundup: Count­ing 1,087 tri­als for coro­n­avirus, R&D ex­perts say much of it is a com­plete waste; WHO sci­en­tist por­tends it will be 'years' be­fore Covid-19 threat will be con­tained

There are good ex­am­ples of R&D pro­grams for Covid-19 drugs and vac­cines, such as CEPI’s plan to ad­vance a slate of new pro­grams. But if you pull back and look at a land­scape of more than 1,000 clin­i­cal tri­als now un­der­way try­ing to make a mark, the field is a mess.

That, in blunt trans­la­tion, is the point of a new op-ed piece in the BMJ penned by Paul Glasziou, di­rec­tor of the In­sti­tute for Ev­i­dence Based Health­care, and col­leagues.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER